Difference between revisions of "Fibrinogen alpha chain (TG2)"

From MyMediaWiki
Jump to: navigation, search
m
 
(3 intermediate revisions by one other user not shown)
Line 1: Line 1:
 
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
 
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;"
! {{infobox header}}| '''{{PAGENAME}}'''  
+
! {infobox header}| '''{{PAGENAME}}'''  
|-
 
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:{{PAGENAME}}.png|200px|{{PAGENAME}}]]
 
 
|-
 
|-
 
| Substrate peptide name
 
| Substrate peptide name
| {{PAGENAME}}
+
| Fibrinogen alpha chain
 
|-
 
|-
 
| Synonyms
 
| Synonyms
Line 47: Line 45:
 
|-
 
|-
 
| Surface accessibility
 
| Surface accessibility
| [http://gibk21.bse.kyutech.ac.jp/asaview/all/2btfA.pdf ASAView] pdf
+
|  
 
|-
 
|-
 
| Disorder prediction
 
| Disorder prediction
Line 58: Line 56:
 
|  
 
|  
 
|-
 
|-
| {{infobox header}} |  
+
| {infobox header} |  
 
|-
 
|-
 
|}
 
|}
  
 
[[Category:Tissue transglutaminase|*]]
 
[[Category:Tissue transglutaminase|*]]

Latest revision as of 11:37, 10 March 2015

Fibrinogen alpha chain (TG2)
Substrate peptide name Fibrinogen alpha chain
Synonyms -
Determination type In vitro
Source Homo sapiens
Subcellular localization Extracellular; plasma
Swissprot ID P02671
Reactive glutamines Q328, Q366
Reactive lysines K148, K230, K303, K413
Substrate sequence GSTGNQNPGSP

SGSTGQWHSES

QLVDMKRELVD

VPPEWKALTDM

GTATWKPGSSG

EYHTEKLVTSK

Structure 1LT9
Surface accessibility
Disorder prediction IUPred
Reference PMID:10816585
Notes